Daniel Barber
2018
In 2018, Daniel Barber earned a total compensation of $2.1M as Chief Operating Officer at Aquestive Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $234,872 |
|---|---|
| Option Awards | $1,055,357 |
| Salary | $319,231 |
| Other | $497,934 |
| Total | $2,107,394 |
Barber received $1.1M in option awards, accounting for 50% of the total pay in 2018.
Barber also received $234.9K in non-equity incentive plan, $319.2K in salary and $497.9K in other compensation.
Rankings
In 2018, Daniel Barber's compensation ranked 5,454th out of 14,244 executives tracked by ExecPay. In other words, Barber earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,454 out of 14,244 | 62nd |
Division Manufacturing | 2,060 out of 5,759 | 64th |
Major group Chemicals And Allied Products | 755 out of 2,122 | 64th |
Industry group Drugs | 633 out of 1,811 | 65th |
Industry Pharmaceutical Preparations | 487 out of 1,385 | 65th |
Source: SEC filing on April 29, 2020.
Barber's colleagues
We found two more compensation records of executives who worked with Daniel Barber at Aquestive Therapeutics in 2018.
News
Aquestive Therapeutics CEO Daniel Barber's 2023 pay jumps 88% to $2.5M
April 26, 2024
Aquestive Therapeutics CEO Keith Kendall's 2021 pay jumps 59% to $2M
April 29, 2022
Aquestive Therapeutics CFO John Maxwell's 2020 pay jumps 24% to $1.3M
May 5, 2021
Aquestive Therapeutics CEO Keith Kendall's 2019 pay falls 67% to $2.6M
April 29, 2020